Vaccine composition for prevention or treatment of SARS-coronavirus-2 infection
The present invention provides a recombinant antigen protein for preventing SARS-coronavirus-2 infection, comprising a polypeptide derived from an S1 subunit of a spike protein of SARS-coronavirus-2 and a polypeptide constituting a tetanus toxin (TT) epitope P2 domain, and a vaccine composition comp...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
03.09.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides a recombinant antigen protein for preventing SARS-coronavirus-2 infection, comprising a polypeptide derived from an S1 subunit of a spike protein of SARS-coronavirus-2 and a polypeptide constituting a tetanus toxin (TT) epitope P2 domain, and a vaccine composition comprising the same. |
---|---|
Bibliography: | Application Number: US202118034141 |